Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sureda

Showing results (171-180 of 249) with videos related to

Pageof 25
Sort By:
Bone Marrow Transplantation|February 9, 2010
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblingsJ L Piñana, D Valcárcel, F Fernández-Avilés, et al.
Bone Marrow Transplantation|July 1, 1996
Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myelomaE Martínez, A Sureda, C D Dalmases, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2009
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysisJ Delgado, S Pillai, N Phillips, et al.
Health and Quality of Life Outcomes|January 16, 2019
Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional studyA Sureda, L Fumadó, M Ferrer, et al.
The Science of the Total Environment|February 27, 2021
Long-term exposure to virgin and seawater exposed microplastic enriched-diet causes liver oxidative stress and inflammation in gilthead seabream Sparus aurata, Linnaeus 1758X Capó, J J Company, C Alomar, et al.
European Journal of Haematology|January 19, 2005
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignanciesD Valcárcel, R Martino, A Sureda, et al.
Bone Marrow Transplantation|October 9, 2007
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphomaC Gisselbrecht, W Bethge, R F Duarte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2018
ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patientsM Hutchings, M Ladetto, C Buske, et al.
Bone Marrow Transplantation|February 18, 1998
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complicationsC Ferrà, S de Sanjosé, C F Lastra, et al.
Haematologica|May 9, 2000
Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante HemopoyéticoE Carreras, J F Tomás, G Sanz, et al.
Pageof 25

Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Bone Marrow Transplantation|February 9, 2010
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblingsJ L Piñana, D Valcárcel, F Fernández-Avilés, et al.
Bone Marrow Transplantation|July 1, 1996
Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myelomaE Martínez, A Sureda, C D Dalmases, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 15, 2009
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysisJ Delgado, S Pillai, N Phillips, et al.
Health and Quality of Life Outcomes|January 16, 2019
Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional studyA Sureda, L Fumadó, M Ferrer, et al.
The Science of the Total Environment|February 27, 2021
Long-term exposure to virgin and seawater exposed microplastic enriched-diet causes liver oxidative stress and inflammation in gilthead seabream Sparus aurata, Linnaeus 1758X Capó, J J Company, C Alomar, et al.
European Journal of Haematology|January 19, 2005
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignanciesD Valcárcel, R Martino, A Sureda, et al.
Bone Marrow Transplantation|October 9, 2007
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphomaC Gisselbrecht, W Bethge, R F Duarte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2018
ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patientsM Hutchings, M Ladetto, C Buske, et al.
Bone Marrow Transplantation|February 18, 1998
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complicationsC Ferrà, S de Sanjosé, C F Lastra, et al.
Haematologica|May 9, 2000
Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante HemopoyéticoE Carreras, J F Tomás, G Sanz, et al.
Pageof 25